US Bancorp’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.74M Buy
112,474
+6,437
+6% +$99.5K ﹤0.01% 906
2025
Q1
$1.58M Sell
106,037
-18,295
-15% -$272K ﹤0.01% 934
2024
Q4
$1.65M Buy
124,332
+21,744
+21% +$288K ﹤0.01% 943
2024
Q3
$1.46M Buy
102,588
+10,925
+12% +$155K ﹤0.01% 973
2024
Q2
$1.19M Sell
91,663
-24,464
-21% -$317K ﹤0.01% 1029
2024
Q1
$1.61M Buy
116,127
+23,450
+25% +$326K ﹤0.01% 920
2023
Q4
$1.32M Sell
92,677
-3,784
-4% -$54K ﹤0.01% 996
2023
Q3
$1.49M Sell
96,461
-85,298
-47% -$1.32M ﹤0.01% 900
2023
Q2
$2.86M Sell
181,759
-41,113
-18% -$646K ﹤0.01% 682
2023
Q1
$3.67M Buy
222,872
+19,782
+10% +$326K 0.01% 624
2022
Q4
$3.17M Buy
203,090
+101,045
+99% +$1.58M 0.01% 663
2022
Q3
$1.32M Buy
102,045
+1,302
+1% +$16.9K ﹤0.01% 936
2022
Q2
$1.41M Sell
100,743
-22,985
-19% -$323K ﹤0.01% 949
2022
Q1
$1.77M Buy
123,728
+16,298
+15% +$233K ﹤0.01% 937
2021
Q4
$1.47M Buy
107,430
+28,301
+36% +$386K ﹤0.01% 1040
2021
Q3
$1.3M Buy
79,129
+24,849
+46% +$407K ﹤0.01% 1060
2021
Q2
$914K Buy
54,280
+113
+0.2% +$1.9K ﹤0.01% 1244
2021
Q1
$989K Buy
54,167
+6,960
+15% +$127K ﹤0.01% 1138
2020
Q4
$859K Buy
47,207
+1,896
+4% +$34.5K ﹤0.01% 1162
2020
Q3
$808K Buy
45,311
+6,103
+16% +$109K ﹤0.01% 1086
2020
Q2
$703K Buy
39,208
+7,096
+22% +$127K ﹤0.01% 1116
2020
Q1
$487K Sell
32,112
-13,771
-30% -$209K ﹤0.01% 1202
2019
Q4
$905K Sell
45,883
-5,438
-11% -$107K ﹤0.01% 1094
2019
Q3
$882K Buy
51,321
+8,006
+18% +$138K ﹤0.01% 1090
2019
Q2
$766K Sell
43,315
-13,483
-24% -$238K ﹤0.01% 1192
2019
Q1
$1.16M Buy
56,798
+43,748
+335% +$891K ﹤0.01% 999
2018
Q4
$220K Buy
+13,050
New +$220K ﹤0.01% 1716